Interestingly, the authors further revealed that SIRT5-facilitated downregulation of the PI3K/AKT/NK-kB pathway reduced as the prostate cancer metastasized from the bone to other tissues [100]. The gene discussed is AKT1; the disease is prostate carcinoma.